Overview

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

Status:
Completed
Trial end date:
2019-07-22
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the influence of tegoprazan on the pharmacodynamics of clopidogrel according to CYP2C19 genotypes following co-administration of tegoprazan and clopidogrel in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
CJ HealthCare Corporation
HK inno.N Corporation
Treatments:
Clopidogrel
Esomeprazole
Ticlopidine